Redbiotec expands its Scientific Advisory Board with the appointment of Prof. Dr. Dr. Christoph U. Schoen
Redbiotec AG, a pioneer in living medicines, is pleased to [...]
Redbiotec expands its expertise – two new appointments
Redbiotec welcomes two new senior people: Dr. Jin Huh, a [...]
Collaboration with LOVIT/ Dr. Antonio Marchini
Redbiotec is pleased to announce the appointment of Dr. Antonio [...]
Tumor immunology expert joining Redbiotec’s SAB
Redbiotec is pleased to welcome Prof. Maries van den Broek, PhD, [...]
Growing traction and growing team for Redbiotec’s oncology program
Big and growing interest in Redbiotec's COMOS and in Redbiotec's engineered bacteria carrying CRISPR. Redbiotec therefore further invests in its promising IO platforms.
Large portfolio of novel bacteria to fight cancer
Redbiotec is currently engineering and producing a number of novel bacteria strains to fight cancer.